Member Info for ForFXSake

I think so. Surely it is in the interest of shareholders for them to announce to the world that they have completed the data package.

That way, all potential partners get to know what we have to offer...not just a chosen few.

Why keep it quiet, if they have?

"Data data data

Oh what’s that’s - not got none ……. ??????????"

Got most of it, just waiting for the last bit.

It's a shame the BoD are playing into your hands.

Nice for IMM holders

It's about time we had a bit of that action over here!

I agree, expected timelines are very important.

The company has pushed back promises to deliver a complete data package (which should have been ready in December) using very loose revised estimates: "early 2022". As usual, they are now pushing this to the wire. This damages investor confidence and makes people wonder if they are actually concealing something about that data.

The same situation applies to the BDD recruitment. They announce they are recruiting someone independently and then do something completely different (outsource the role to DG). What next, outsource the CEO role too?

It gives the impression that there is no real plan and that they are just flying by the seat of their pants all the time.

I'd bet that if they'd have successfully completed the data package earlier then we wouldn't be in a position where Lanstead could end up offloading shares at ridiculous price compared the terms that the deal was arranged under.

This position feels very exposed. It's way past time that we had some stability starting to appear. I thought AR said we were in safe hands when Brindley left. Prove it.

Indeed!

Nice one Dr Gooding.

Does he have 37m shares?
How can we know for sure without those TR1's.

Ditto that Chablard.

unless the company eventually becomes listed...or gets bought out.

If the IP that DG developed in his company since he left Nuformix was worth £500k's worth of Oxilio shares then his holding in Oxilio is now worth more than his holding in NFX.

I wonder if we'll see a TR1 soon

I'm sure there are plenty of people with averages much higher than 2p. I feel sorry for those. They are ones who committed to the company long term and entrusted their money to people who really don't seem to give a toss.

It does seem futile doesn't it B009?

However, it it is possibly a welcome distraction for those who should really be under the spotlight. These ghost posters seem to have switched peoples attention away from the real issue which is that we are almost half way through April and have no news on the durability results thar we should have received before our last CEO left.

What is going on inside this company?

I find it odd that DG failed to report his position along with the rest of them.

Is it possible that he topped up his holding within a timeframe that effectively negated the need to report or would he be required to do so in any event?

When does "Early 2002" end?

Must be some news soon..even if it's just to tell us that the durability results will now be ready in late 2022.

Farce!

Thanks for pointing that out Whimax, although I think that was made perfectly clear in the post.

The only way that all NFX shareholders can be assured that all prospective partners will be treated fairly on a level playing field is to appoint a business development consultant who does not stand to gain any more through deals struck with particular partners than they would through just holding NFX shares in isolation.

Regardless of whether or not DG is still operating through LSHS, he now appears to have a valuable stake in Oxilio.

If Oxilio ever enter the frame for future deals on NXP002/NXP004 or attempt to acquire Nuformix as a whole then it could raise a question mark over the integrity of the appointment and any resulting deal.

"Something like this might be the best return for current shareholders rather than yet more drift & dilution."

Really? Another deal along the lines of OXL001? Did that halt the drift & dilution?

...and just how are those talks going OBW? Do we need if contact has even been made with AZ?

NXP004 would fit the bill though.

DG now has direct links with both Oxilio & Trx. If either of them could have interests in NXP002 then how is that not a clear conflict of interest? Without knowing what OXL002 is based upon then we have no way of knowing. We cannot expect DG to be impartial while that is an unknown.

I find it both astounding and insulting if, as Soup says, DG has been paid £500k in shares while Nuformix have only received a tenth of that so far as part of the Oxilio deal for NXP001 and look set to receive nothing more until at least the end of the year.